Hey all, you know, I'm the data guy and there's a lot of great data coming out lately.

So I'm going to do a short here and answer the biggest question of all.

You know, what about the MRNA kind of effectiveness and cost benefit?

Well, Dr. Claire Craig had an excellent thread recently.

Straight from the UK government publications and everything in here will be published government data, right?

So no censorship.

But it's fantastic and very insightful.

And I'm going to add in a little bit more data that I have been sharing since late 20, early 21.

And it at a very early stage began to answer the question of cost benefit around mass

medication campaigns including coercion and kind of mandates and stuff we should never see in

the civilized society but in any case enjoy this little bit of analysis yep does, there's nothing I love more than published data.

Hope you liked my splash screen also. But anyway, we're going to make a very important quick point here.

There's the link to Metatron substack. And this data was released possibly mistakenly by the Canadian

authorities way back. And it just shows a key point that in the

first 14 days post the V, you have a relatively large hump, right, of hospitalizations, for whatever

reason. And after that, they fall off. So the first 14 days post the V is a very important clocking up of maybe half of the

hospitalizations you'd be interested in, this crucial period. And for mortality, it was similar,

the deaths with a positive PCR. The first 14 days post the V was a very important period. We clocked up a lot of data.

Now, this is a crucial thing to recognize because it can lead to magic.

In other words, if you take out the first 14 days post the V from your data,

you can create an utterly artificial data set.

And I think that's been happening all across publications and even government data.

...